Bacteroides thetaiotaomicron Ameliorates Colon Inflammation in Preclinical Models of Crohn’s Disease
Open accessThe DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.
Abstract
Background: Alterations in the gut microbiota are strongly associated with the development of inflammatory bowel disease (IBD), particularly with Crohn's disease, which is characterized by reduced abundance of commensal anaerobic bacteria including members of the Bacteroides genus. Our aim was to investigate the protective effects of Bacteroides thetaiotaomicron, an abundant member of this genus, in different rodent models of IBD. Methods: We assessed the effect of B. thetaiotaomicron administration on primary readouts of colitis (weight loss, histopathology, and immune parameters) in dextran sodium sulphate (DSS) and interleukin-10 knockout (IL10KO) models of IBD. Efficacy of a freeze-dried bacterial formulation and a purified recombinant protein of B. thetaiotaomicron was also investigated. Results: B. thetaiotaomicron showed protective effects in both DSS and IL10KO rodent models, as demonstrated by significant amelioration of weight loss, colon shortening, histopathological damage and immune activation. This efficacy was not exclusive to actively growing bacterial preparations but was retained by freeze-dried cells of B. thetaiotaomicron. A pirin-like protein (PLP) of B. thetaiotaomicron, identified by microarray analysis during coculture of the bacterial strain with Caco-2 cells, reduced pro-inflammatory NF-κB signalling in these intestinal epithelial cells. Recombinant PLP partially recapitulated the effect of the whole strain in a rat DSS model. Conclusions: B. thetaiotaomicron displays strong efficacy in preclinical models of IBD and protects against weight loss, histopathological changes in the colon and inflammatory markers. These data indicate that the live strain or its products may be a novel alternative to current treatment options for Crohn's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The enrichment in Bacteroidota can lead to a reduction in intestinal inflammation [18,19,20].”
From A Clinical Outcome of the Anti-PD-1 Therapy of Melanoma in Polish Patients Is Mediated by Population-Specific Gut Microbiome Composition (2022) · cites this paper as [19]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
Gevers, D., Kugathasan, S., Denson, L. A., Vázquez-Baeza, Y., Van Treuren, W., Ren, B., Schwager, E., Knights, D., Song, S. J., Yassour, M., et al. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.02.005 · Cited by 3,220
Cytokines in inflammatory bowel disease
Neurath, M. F. (2014) · Nature Reviews Immunology · doi:10.1038/nri3661 · Cited by 2,706
A microbial symbiosis factor prevents intestinal inflammatory disease
Mazmanian, S. K., Round, J. L., & Kasper, D. L. (2008) · Nature · doi:10.1038/nature07008 · Cited by 2,340
Nasir, O. (2013) · Kidney and Blood Pressure Research · doi:10.1159/000350152 · Cited by 2,331
Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach
Manichanh, C., Rigottier-Gois, L., Bonnaud, E., Gloux, K., Pelletier, E., Frangeul, L., Nalin, R., Jarrin, C., Chardon, P., Marteau, P., et al. (2006) · Gut · doi:10.1136/gut.2005.073817 · Cited by 2,277
Epidemiology and Natural History of Inflammatory Bowel Diseases
Cosnes, J., Gower–Rousseau, C., Seksik, P., & Cortot, A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.01.055 · Cited by 2,211
Molecular Analysis of Commensal Host-Microbial Relationships in the Intestine
Hooper, L. V., Wong, M. H., Thelin, A., Hansson, L., Falk, P. G., & Gordon, J. I. (2001) · Science · doi:10.1126/science.291.5505.881 · Cited by 2,202
Chemically induced mouse models of acute and chronic intestinal inflammation
Wirtz, S., Popp, V., Kindermann, M., Gerlach, K., Weigmann, B., Fichtner-Feigl, S., & Neurath, M. F. (2017) · Nature Protocols · doi:10.1038/nprot.2017.044 · Cited by 1,575
Ott, S. J., Musfeldt, M., Wenderoth, D. F., Hampe, J., Brant, O., Fölsch, U. R., Timmis, K. N., & Schreiber, S. (2004) · Gut · doi:10.1136/gut.2003.025403 · Cited by 1,311
Cited by
Inflammatory bowel diseases (IBD) and the microbiome-searching the crime scene for clues
Lee, M., & Chang, E. B. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.09.056 · Cited by 645
Mahmud, M. R., Akter, S., Tamanna, S. K., Mazumder, L., Esti, I. Z., Banerjee, S., Akter, S., Hasan, M. R., Acharjee, M., Hossain, M. S., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2096995 · Cited by 466
Whole-Virome Analysis Sheds Light on Viral Dark Matter in Inflammatory Bowel Disease
Clooney, A. G., Sutton, T. D. S., Shkoporov, A. N., Holohan, R. K., Daly, K. M., O’Regan, O., Ryan, F. J., Draper, L. A., Plevy, S. E., Ross, R. P., et al. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.10.009 · Cited by 452
Microbiota‐derived extracellular vesicles in interkingdom communication in the gut
Díaz‐Garrido, N., Badia, J., & Baldomà, L. (2021) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12161 · Cited by 405
“thetaiotaomicron have been proved in preclinical models of CD treated with live bacterial suspensions (Delday et al., 2019).”
BackgroundBacteroides utilization for dietary polysaccharides and their beneficial effects on gut health
Cheng, J., Hu, J., Geng, F., & Nie, S. (2022) · Food Science and Human Wellness · doi:10.1016/j.fshw.2022.04.002 · Cited by 268
Guo, C., Wang, Y., Zhang, S., Zhang, X., Du, Z., Li, M., & Ding, K. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.03.137 · Cited by 267
Relationships Between Vitamin D, Gut Microbiome, and Systemic Autoimmunity
Yamamoto, E. A., & Jørgensen, T. N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03141 · Cited by 256
“thetaiotaomicron colonization demonstrated therapeutic properties in preclinical models of CD (90), although separate studies showed that B.”
ResultDysbiosis Disrupts Gut Immune Homeostasis and Promotes Gastric Diseases
Toor, D., Wsson, M. K., Kumar, P., Karthikeyan, G., Kaushik, N. K., Goel, C., Singh, S., Kumar, A., & Prakash, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102432 · Cited by 177
Henneke, L., Schlicht, K., Andreani, N. A., Hollstein, T., Demetrowitsch, T. J., Knappe, C., Hartmann, K., Jensen‐Kroll, J., Rohmann, N., Pohlschneider, D., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2057778 · Cited by 172
“Since inflammatory comorbidities (inflammatory bowel disease (IBD) and psoriasis) other than metabolic diseases that are known to affect the microbial composition, the presence of such diseases and the proband age were included as covariates.(31,32) In some analysis when marked accordingly, we additionally used BMI as…”
MethodRosario, D., Bidkhori, G., Lee, S., Bedarf, J., Hildebrand, F., Le Chatelier, E., Uhlen, M., Ehrlich, S. D., Proctor, G., Wüllner, U., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108807 · Cited by 167
Durant, L. R., Stentz, R., Noble, A., Brooks, J., Gicheva, N., Reddi, D., O’Connor, M. J., Hoyles, L., McCartney, A. L., Man, R., et al. (2020) · Microbiome · doi:10.1186/s40168-020-00868-z · Cited by 165
Hiippala, K., Kainulainen, V., Suutarinen, M., Heini, T., Bowers, J. R., Jasso-Selles, D., Lemmer, D., Valentine, M., Barnes, R., Engelthaler, D. M., et al. (2020) · Nutrients · doi:10.3390/nu12040935 · Cited by 141
“in ameliorating intestinal inflammation [19,48,51,57,58].”
Bacteroidetes Species Are Correlated with Disease Activity in Ulcerative Colitis
Nomura, K., Ishikawa, D., Okahara, K., Ito, S., Haga, K., Takahashi, M., Arakawa, A., Shibuya, T., Osada, T., Kuwahara-Arai, K., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081749 · Cited by 150
“The finding supports the fact that Bacteroides thetaiotaomicron suppresses inflammation of IBD [18].”
BackgroundResultInfluentialLi, K., Hao, Z., Du, J., Gao, Y., Yang, S., & Zhou, Y. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107183 · Cited by 149
Wang, X., Cai, Z., Wang, Q., Wu, C., Sun, Y., Wang, Z., Xu, X., Xue, W., Cao, Z., Zhang, M., et al. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.11.005 · Cited by 137
Gul, L., Módos, D., Fonseca, S., Madgwick, M., Thomas, J. P., Sudhakar, P., Booth, C., Stentz, R., Carding, S. R., & Korcsmáros, T. (2022) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12189 · Cited by 132
“Structural, compositional and functional alterations of the microbiota (“dysbiosis”) are associated with various GI-related diseases, including Crohn’s disease (CD) and ulcerative colitis (UC), two major forms of inflammatory bowel disease (IBD) [1].”
BackgroundWu, R., Xiong, R., Li, Y., Chen, J., & Yan, R. (2023) · Journal of Autoimmunity · doi:10.1016/j.jaut.2023.103062 · Cited by 126
Deciphering diet-gut microbiota-host interplay: Investigations of pectin
Tan, H., & Nie, S. (2020) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2020.10.010 · Cited by 123
Ihekweazu, F. D., Engevik, M. A., Ruan, W. H., Shi, Z., Fultz, R., Engevik, K. A., Chang‐Graham, A. L., Freeborn, J., Park, E. S., Venable, S. F., et al. (2021) · American Journal Of Pathology · doi:10.1016/j.ajpath.2021.01.009 · Cited by 105
“Bacteroides thetaiotaomicron can suppress inflammation in multiple models of murine colitis.(7) Similarly, B.”
BackgroundLiu, L., Xu, M., Lan, R., Hu, D., Li, X., Qiao, L., Zhang, S., Lin, X., Yang, J., Ren, Z., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1036196 · Cited by 103
Gut microbiota in pathophysiology, diagnosis, and therapeutics of inflammatory bowel disease
Pandey, H., Jain, D., Tang, D. W. T., Wong, S. H., & Lal, D. (2023) · Intestinal Research · doi:10.5217/ir.2023.00080 · Cited by 102
Mishima, Y., & Sartor, R. B. (2019) · Journal of Gastroenterology · doi:10.1007/s00535-019-01618-1 · Cited by 98
“butyricum) [12, 78, 131] and Bacteroides species (thetaiotaomicron [132], uniformis [133], ovatus [134], and fragilis [79, 80]).”
BackgroundMucosal host-microbe interactions associate with clinical phenotypes in inflammatory bowel disease
Hu, S., Bourgonje, A. R., Gaćeša, R., Jansen, B. H., Björk, J. R., Bangma, A., Hidding, I. J., van Dullemen, H. M., Visschedijk, M. C., Faber, K. N., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45855-2 · Cited by 96
Comparative Analysis of the Microbiome across the Gut–Skin Axis in Atopic Dermatitis
Park, D. H., Kim, J. W., Park, H., & Hahm, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084228 · Cited by 99
“Certain species of Bacteroides genus, such as Bacteroides thetaiotaomicron, have an anti-inflammatory nature, which can be essential for alleviating allergic symptoms of AD as well as chronic inflammatory diseases including Crohn’s disease [82].”
BackgroundAktar, R., Parkar, N., Stentz, R., Baumard, L., Parker, A., Goldson, A., Brion, A., Carding, S., Blackshaw, A., & Peiris, M. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1766936 · Cited by 80
CRISPR/Cas-Based Genome Editing for Human Gut Commensal Bacteroides Species
Zheng, L., Tan, Y., Hu, Y., Shen, J., Qu, Z., Chen, X., Ho, C. L., Leung, E. L., Zhao, W., & Dai, L. (2022) · ACS Synthetic Biology · doi:10.1021/acssynbio.1c00543 · Cited by 87
Cao, W., Zheng, C., Xu, X., Jin, R., Huang, F., Shi, M., He, Z., Luo, Y., Liu, L., Liu, Z., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1076245 · Cited by 87
Kim, S., Lee, J., Shin, S. G., Kim, J. K., Silwal, P., Kim, Y. J., Shin, N., Kim, P. S., Won, M., Lee, S., et al. (2020) · Autophagy · doi:10.1080/15548627.2020.1847460 · Cited by 81
Probiotic-Based Intervention in the Treatment of Ulcerative Colitis: Conventional and New Approaches
Štofilová, J., Kvaková, M., Kamlárová, A., Hijová, E., Bertková, I., & Guľašová, Z. (2022) · Biomedicines · doi:10.3390/biomedicines10092236 · Cited by 81
Huang, H., Jiang, J., Wang, X., Jiang, K., & Cao, H. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102428 · Cited by 78
Fonseca, S., Carvalho, A. L., Miquel-Clopés, A., Jones, E. J., Juodeikis, R., Stentz, R., & Carding, S. R. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1050271 · Cited by 75
“Indeed, administration of live or dead (freeze dried) Bt to IL-10r-deficient mice protects the animals from developing colitis (Delday et al., 2019) which may involve different bacterial mediators and multiple interactions with host cells.”
BackgroundExploring the Probiotic Potential of Bacteroides spp. Within One Health Paradigm
Tufail, M. A., & Schmitz, R. A. (2024) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10370-9 · Cited by 75
“Additionally, Bacteroides thetaiotaomi-cron possesses notable anti-inflammatory properties and has demonstrated the ability to enhance mucosal barrier function, restrict pathogen infiltration, and alleviate colon inflammation in preclinical models of Crohn’s disease [37].”
A metagenome-wide association study of gut microbiome and visceral fat accumulation
Nie, X., Chen, J., Ma, X., Ni, Y., Shen, Y., Yu, H., Panagiotou, G., & Bao, Y. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.09.026 · Cited by 74
“thetaiotaomicron ameliorates colon inflammation in preclinical models of Crohn’s disease [29], while B.”
BackgroundA Metagenome-Wide Association Study of the Gut Microbiome and Metabolic Syndrome
Qin, Q., Su, Y., Yang, Y., Chen, J., Li, T., Gao, X., Yan, H., Wang, Y., Wang, J., Wang, S., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.682721 · Cited by 73
“thetaiotaomicron (Delday et al., 2019) promoted endoscopic mucosal healing for sustained remission by reducing pro-inflammatory NF-κB signaling in these intestinal epithelial cells.”
BackgroundMannose Treatment: A Promising Novel Strategy to Suppress Inflammation
Zhang, W., Cheng, H., Gui, Y., Zhan, Q., Li, S., Qiao, W., & Tong, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.756920 · Cited by 73
Oba, S., Sunagawa, T., Tanihiro, R., Awashima, K., Sugiyama, H., Odani, T., Nakamura, Y., Kondo, A., Sasaki, D., & Sasaki, K. (2020) · Scientific Reports · doi:10.1038/s41598-020-74379-0 · Cited by 70
Dietary Organic Acids Modulate Gut Microbiota and Improve Growth Performance of Nursery Pigs
Wei, X., Bottoms, K. A., Stein, H. H., Blavi, L., Bradley, C. L., Bergstrom, J. R., Knapp, J., Story, R., Maxwell, C., Tsai, T.-C., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9010110 · Cited by 64
“Faecalibacterium appeared on d 7 and persiste until the end of the nursery phase; however, the largely enriched Campylobacter and Bacteroides on d 7 were almost absent on d 21 and d 40.”
BackgroundSartorio, M. G., Valguarnera, E., Hsu, F., & Feldman, M. F. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00634-21 · Cited by 63
Gut microbiota in the early stage of Crohn’s disease has unique characteristics
Ma, X., Lu, X., Zhang, W., Yang, L., Wang, D., Xu, J., Jia, Y., Wang, X., Xie, H., Li, S., et al. (2022) · Gut Pathogens · doi:10.1186/s13099-022-00521-0 · Cited by 65
“Oral administration of P. distasonis to mice with DSS-induced colitis could significantly aggravate the inflammation [35].”
BackgroundInfluentialGut biofilms:Bacteroidesas model symbionts to study biofilm formation by intestinal anaerobes
Béchon, N., & Ghigo, J. (2021) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuab054 · Cited by 62
Cao, W., Guan, S., Yuan, Y., Wang, Y., Yiasmin, M. N., Liu, Y., Tong, Y., Yu, S., & Hua, X. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2253547 · Cited by 62
“Similarly, butyrate binding to GPR109A is essential in promoting the expression of anti-inflammatory molecules (e.g., IL-10, IL-1β and IFN-γ) and suppressing the pro-inflammatory-related pathway (e.g., NF-κB and MAPK) (Breyner et al. 2017; Delday et al. 2019; Zhan et al. 2018).”
Singh, N., Singh, V., Nand, S., Mishra, V., Vamanu, E., & Singh, M. P. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113958 · Cited by 57
Chen, L., Wang, J., Yi, J., Liu, Y., Yu, Z., Chen, S., & Liu, X. (2021) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15562 · Cited by 55
Direct and Indirect Evidence of Effects of Bacteroides spp. on Obesity and Inflammation
Wu, L., Park, S., & Kim, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010438 · Cited by 55
Intestinal microbiota controls graft-versus-host disease independent of donor-host genetic disparity
Koyama, M., Hippe, D. S., Srinivasan, S., Proll, S. C., Miltiadous, O., Li, N., Zhang, P., Ensbey, K. S., Hoffman, N. G., Schmidt, C. R., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.06.024 · Cited by 54
Systems and synthetic biology-driven engineering of live bacterial therapeutics
Kim, K., Kang, M., & Cho, B. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1267378 · Cited by 55
The Gut Microbiome Advances Precision Medicine and Diagnostics for Inflammatory Bowel Diseases
Mousa, W. K., & Ali, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011259 · Cited by 56
“B . thetaiotaomicron has shown a protective effect against colitis through the secretion of pirin-like protein, which reduces the pro-inflammatory NF-κ B signaling pathway [102].”
BackgroundGut bacteria Prevotellaceae related lithocholic acid metabolism promotes colonic inflammation
Chen, L., Ye, Z., Li, J., Wang, L., Chen, Y., Yu, M., Han, J., Huang, J., Li, D., Lv, Y., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-024-05873-6 · Cited by 52
Tanihiro, R., Sakano, K., Oba, S., Nakamura, C., Ohki, K., Hirota, T., Sugiyama, H., Ebihara, S., & Nakamura, Y. (2020) · Nutrients · doi:10.3390/nu12123673 · Cited by 52
Evaluation of the Effects of Different Bacteroides vulgatus Strains against DSS-Induced Colitis
Li, S., Wang, C., Zhang, C., Luo, Y., Cheng, Q., Yu, L., & Sun, Z. (2021) · Journal of Immunology Research · doi:10.1155/2021/9117805 · Cited by 51
“Furthermore, animal studies related to colitis have demonstrated that several strains of Bacteroides, including Bacteroides fragilis NCTC 9343, Bacteroides thetaiotaomicron DSM 2079, and Bacteroides cellulosilyticus DSM 14838, can expand the population of interleukin- (IL-) 10-producing CD4CD45RB T cells [8], ameliora…”
BackgroundSimotang Alleviates the Gastrointestinal Side Effects of Chemotherapy by Altering Gut Microbiota
Deng, L., Zhou, X., Lan, Z., Tang, K., Zhu, X.-X., Mo, X., Zhao, Z., Zhao, Z., & Wu, M.-S. (2022) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2110.10018 · Cited by 45
“discovered that the relative abundance of Bacteroides was reduced in inflammatory bowel diseases (such as Crohn's disease) [26].”
BackgroundHost–pathobiont interactions in Crohn’s disease
Caruso, R., Lo, B. C., Chen, G., & Núñez, G. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00997-y · Cited by 44
“In line with these observations B. thetaiotaomicron exerts anti-inflammatory effects in SPF colitis-prone Il10 −/− mice 159 .”
Pei, T., Li, W., Zhou, Z., Zhang, Q., Yu, G., Yin, S., Chen, H., & Tang, J. (2025) · Microbiological Research · doi:10.1016/j.micres.2025.128211 · Cited by 43
Yue, S., Shan, B., Peng, C., Tan, C., Wang, Q., & Gong, J. (2022) · Food & Function · doi:10.1039/d1fo03374c · Cited by 45
Zhang, J., Xu, X., Li, N., Cao, L., Sun, Y., Wang, J., He, S., Si, J., & Qing, D. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174730 · Cited by 41
Microbiome Dysbiosis: A Pathological Mechanism at the Intersection of Obesity and Glaucoma
Pezzino, S., Sofia, M., Greco, L. P., Litrico, G., Filippello, G., Sarvà, I., Greca, G. L., & Latteri, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021166 · Cited by 41
Microbiota and human diseases: dietary correction
Karpeeva, Y. S., Новикова, В. П., Хавкин, А. И., Kovtun, T. A., Макаркин, Д. В., & Fedotova, O. B. (2020) · Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) · doi:10.21508/1027-4065-2020-65-5-116-125 · Cited by 40
“Morexella Ассоциируется с бронхиальной астмой, ХОБЛ, отитом, синуситом, блефароконъюнктивитом, эндокардитом, артритом [49, 50]”
Bosch, D. E., Abbasian, R., Parajuli, B., Peterson, S. B., & Mougous, J. D. (2023) · mBio · doi:10.1128/mbio.01039-23 · Cited by 39
“In summary, correlative human studies suggest that alterations among specific Bacteroidaceae may contribute IBD progres sion, and patterns differ between Crohn’s disease and UC.”
BackgroundInfluentialXu, B., Fu, Y., Yin, N., Qin, W., Huang, Z., Xiao, W., Huang, H., Mei, Q., Fan, J., Zeng, Y., et al. (2024) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00303.2023 · Cited by 39
Kim, K., Choe, D., Song, Y., Kang, M., Lee, S., Lee, D., & Cho, B. (2021) · Metabolic Engineering · doi:10.1016/j.ymben.2021.10.005 · Cited by 39
Hansen, R., Sanderson, I. R., Muhammed, R., Allen, S. J., Tzivinikos, C., Henderson, P., Gervais, L., Jeffery, I. B., Mullins, D., O’Herlihy, E. A., et al. (2020) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000287 · Cited by 38
“thetaiotaomicron ameliorated weight loss, histological damage, and immunological activation, including reduced expression of TNFa in the DSS model (18).”
BackgroundRole of the Microbiome in the Pathogenesis of COVID-19
De, R., & Dutta, S. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.736397 · Cited by 38
“Recombinant PLP was found to partially recapitulate the effect of the whole strain in a rat DSS model (Delday et al., 2019).”
BackgroundInfluentialLiu, X., Zhang, B., Zhang, Y., Li, W., Yin, J., Shi, A., Wang, J., & Wang, S. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c08305 · Cited by 38
Kulecka, M., Frączek, B., Bałabas, A., Czarnowski, P., Żeber‐Lubecka, N., Zapała, B., Bagińska, K., Głowienka, M., Szot, M., Skorko, M., et al. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1092846 · Cited by 37
Pietrzak, B., Tomela, K., Olejnik-Schmidt, A., Galus, Ł., Mackiewicz, J., Kaczmarek, M., Mackiewicz, A., & Schmidt, M. (2022) · Cancers · doi:10.3390/cancers14215369 · Cited by 36
Liu, F., Wang, T. T. Y., Tang, Q., Xue, C., Li, R. W., & Wu, V. C. H. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900455 · Cited by 36
Ecological Structuring of Temperate Bacteriophages in the Inflammatory Bowel Disease-Affected Gut
Nishiyama, H., Endo, H., Blanc‐Mathieu, R., & Ogata, H. (2020) · Microorganisms · doi:10.3390/microorganisms8111663 · Cited by 36
Olivera‐Castillo, L., Grant, G., Kantún-Moreno, N., Barrera-Pérez, H. A. M., Montero, J., Olvera-Novoa, M. A., Carrillo‐Cocom, L. M., Acevedo‐Fernández, J. J., Puerto-Castillo, C., May-Solis, V., et al. (2020) · Nutrients · doi:10.3390/nu12061698 · Cited by 35
Self-citationInflammatory Bowel Diseases: Host-Microbial-Environmental Interactions in Dysbiosis
Colquhoun, C. M., Duncan, M., & Grant, G. (2020) · Diseases · doi:10.3390/diseases8020013 · Cited by 34
“thetaiotaomicron, proteins that down-regulate NF-κB have been identified [77,115].”
BackgroundSelf-citationSun, X., Chen, Z., Yu, L., Zeng, W., Sun, B., Fan, H., & Bai, Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1205323 · Cited by 33
“IBD includes two types: ulcerative colitis (UC) and Crohn’s disease (CD), both of which are associated with gut dysbiosis that occurs after the intestinal microbiota undergoes compositional and metabolic changes (Ni et al., 2017; Shen et al., 2018).”
BackgroundInfluentialLiu, K., Cai, Y., Song, K., Yuan, R., & Zou, J. (2023) · The EPMA Journal · doi:10.1007/s13167-023-00321-9 · Cited by 32
Ishikawa, D., Zhang, X., Nomura, K., Shibuya, T., Hojo, M., Yamashita, M., Koizumi, S., Yamazaki, F., Iwamoto, S., Saito, M., et al. (2024) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izae080 · Cited by 32
Aslam, H., Trakman, G., Dissanayake, T., Todd, E., Harrison, P., Alby, C., Jabeen, T., Gamage, E., Travica, N., Marshall, S., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-025-07428-9 · Cited by 30
“[ 85 ] ↑ B a c t e r o i d e s t h e t a i o t a o m i c r o n G r a m - , a n a e r o b i c , n o n - s p o r e f o r m i n g , n o n - m o t i l e P o ss e ss p r o t e c t i v e e ff e c t s a g a i n s t I B D [ 182 ] .”
de Jesus, L. C. L., Freitas, A. D. S., Dutra, J. D. C. F., Campos, G. M., Américo, M. F., Laguna, J. G., Dornelas, E. G., Carvalho, R. D. D. O., Vital, K. D., Fernandes, S. O. A., et al. (2024) · Food Research International · doi:10.1016/j.foodres.2024.114322 · Cited by 30
Liu, C., Liu, L., Tian, Z., Zhan, S., Qiu, Y., Li, M., Li, T., Mao, R., Zhang, S., Chen, M., et al. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.11.025 · Cited by 30
Schütz, B., Krause, F. F., Taudte, R. V., Zaiss, M. M., Luu, M., & Visekruna, A. (2025) · European Journal of Immunology · doi:10.1002/eji.202451594 · Cited by 30
Mouse Models of Intestinal Fibrosis
Li, J., Dejanovic, D., Zangara, M. T., Chandra, J., McDonald, C., & Rieder, F. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1382-5_26 · Cited by 30
Liang, X., Xie, Y., Liu, X., Xu, H., Ren, H., Tang, S., Liu, Q., Huang, M., Shao, X., Li, C., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00390 · Cited by 30
Luo, Y., Lan, C., Ren, W., Wu, A., Yu, B., He, J., & Chen, D. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.04.016 · Cited by 29
“In clinical models of inflammatory bowel disease, B. thetaiotaomicron has demonstrated significant therapeutic potential by preventing weight loss, mitigating colonic tissue pathology, and reducing levels of inflam-matory markers [12].”
Biomarker discovery in inflammatory bowel diseases using network-based feature selection
Abbas, M. M., Matta, J., Le, T., Bensmail, H., Obafemi-Ajayi, T., Honavar, V., & EL‐Manzalawy, Y. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225382 · Cited by 29
“Bacteroides is a dominant and biologically important bacteria genus in the microbiota of the human gastrointestinal tract [54] and Oscillospira is an under-studied bacterial genus that is hard to cultivate but is consistently being identified in several human gut microbiota association studies [55].”
BackgroundSheh, A., Artim, S. C., Burns, M. A., Molina-Mora, J. A., Lee, M. A., Dzink-Fox, J., Muthupalani, S., & Fox, J. G. (2022) · Scientific Reports · doi:10.1038/s41598-022-08255-4 · Cited by 29
Kang, R., Wang, W., Liu, Y., Huang, S., Xu, J., Zhao, L., Zhang, J., Ji, C., Wang, Z., Hu, Y., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.928865 · Cited by 28
“YS also increased the abundance of Bacteroidales, which was considered as an intestinal beneficial bacterial, which can increase immune function and improve intestinal health (60).”
BackgroundLiu, X., Mei, L., Wang, J., Liu, X., Yang, Y., Wu, Z., & Ji, Y. (2025) · Food Research International · doi:10.1016/j.foodres.2025.116186 · Cited by 27
Fecal microbiota changes in NZB/W F1 mice after induction of lupus disease
Chen, Y., Hsieh, A.-H., Wang, L.-C., Huang, Y.-J., Tsai, Y.-C., Tseng, W.-Y., Kuo, Y., Luo, S., Yu, K., & Kuo, C. (2021) · Scientific Reports · doi:10.1038/s41598-021-02422-9 · Cited by 27
Interactions between dietary cholesterol and intestinal flora and their effects on host health
Liu, Y., Xiao, H., Wang, Z., Pan, Q., Zhao, X., & Lu, B. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2276883 · Cited by 27
“Treatment of live Bacteroides thetaiotaomi-cron ameliorated the weight loss, histopathological damage, and inflammation of chemical-induced or gene-modified UC mice (Delday et al. 2019).”
Zou, L., Yang, Y., Zhan, J., Cheng, J., Fu, Y., Cao, Y., Yan, X., Wang, Y., & Wu, C. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116302 · Cited by 27
Abraham, L., Raise, A., Beney, L., Lapaquette, P., & Rieu, A. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2552344 · Cited by 26
“40 In addition, B. thetaiotaomicron appears to exhibit a favorable safety profile and is well tolerated in patients with Crohn’s disease.”
Wang, Q., Li, Y., Lv, L., Jiang, H., Ren, Y., Wang, S., Lu, Y., Wu, Z., Shen, J. F., Jiang, S., et al. (2022) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-022-11946-7 · Cited by 26
Zheng, W., Jia, J., Tang, S., Song, S., & Ai, C. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.126256 · Cited by 26
Zhao, H., Wang, Q., Zhao, J., Wang, D., Liu, H., Gao, P., Shen, Y., Wu, T., Wu, X., Zhao, Y., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115985 · Cited by 26
Zhao, J., Hao, S., Chen, Y., Ye, X., Fang, P., & Hu, H. (2024) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2024.113798 · Cited by 26
Magadán‐Corpas, P., Pérez‐Valero, Á., Ye, S., Sordon, S., Huszcza, E., Popłoński, J., Villar, C. J., & Lombó, F. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063236 · Cited by 26
“…were observed in the family Prevotellaceae in the xanthohumol cohort (Table 2, Supplementary Figure S3) [39,50], as well as in the species Bacteroides dorei and Bacteroides thetaiotaomicron , both being species reported with anti-inflammatory activity (Table 3, Supplementary Figure S5) [51,52].”
BackgroundHe, L., Chen, K., Chen, Z., Chen, C., Zhou, J., Shao, Y., Ma, J., Qiu, Z., Chen, Y., & Zhang, W. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.134370 · Cited by 25
Effects of IQW and IRW on Inflammation and Gut Microbiota in ETEC‐Induced Diarrhea
Liu, N., Zhou, L., Fang, J. Q., Jiang, H., & Liu, G. (2021) · Mediators of Inflammation · doi:10.1155/2021/2752265 · Cited by 24
“A study revealed that IRW functions by regulating and improving the diversity of the intestinal microbiome of the host [35, 36]; our research confirmed this.”
BackgroundReider, S., Watschinger, C., Längle, J., Pachmann, U., Przysiecki, N., Pfister, A., Zollner, A., Tilg, H., Plattner, S., & Moschen, A. R. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12091479 · Cited by 23
Xu, Y., Wang, F., Mi, K., Wang, X., Wang, D., Zhao, Q., Wang, J., Liu, Z., Zhang, Q., Liu, Y., et al. (2023) · iScience · doi:10.1016/j.isci.2023.107515 · Cited by 22
Qi, C., Tu, H., Zhao, Y., Zhou, J., Chen, J., Hu, H., Yu, R., & Sun, J. (2022) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202200444 · Cited by 21
Egg yolk phosphatidylcholine alleviates DSS-induced colitis in BALB/c mice
Wen, Y., Tan, L., Chen, S., Wu, N., Yao, Y., Xu, L., Xu, M., Zhao, Y., & Tu, Y. (2023) · Food & Function · doi:10.1039/d3fo02885b · Cited by 21
Tran, T. M. T., Senger, S., Baldassarre, M., Brosnan, R. A., Cristofori, F., Crocco, M., Santis, S. D., Elli, L., Faherty, C. S., Francavilla, R., et al. (2024) · Pediatric Research · doi:10.1038/s41390-023-02960-0 · Cited by 21
Sambruni, G., Macandog, A. D. G., Wirbel, J., Cagnina, D., Catozzi, C., Dallavilla, T., Borgo, F., Fazio, N., Romario, U. F., Petz, W. L., et al. (2023) · Genome Medicine · doi:10.1186/s13073-023-01180-9 · Cited by 20
Metadata
- Authors
- Delday, M., Mulder, I., Logan, E. T., & Grant, G.
- Affiliations
- University of Aberdeen (GB)
- 4D Pharma Research Ltd, Life Science Innovation Building, Aberdeen, UK
- Corresponding author
- Mulder, Imke
- Venue
- Inflammatory Bowel Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-09-12
- Volume
- 25
- Issue
- 1
- Pages
- 85-96
- ISSN
- 1078-0998 (ISSN-L)
- 1536-4844
- PMC
- PMC6290787
- OpenAlex
- W2890463030
- Cited by
- 193
- References
- 59
- Citations by year
- 2026: 20 · 2025: 33 · 2024: 32 · 2023: 31 · 2022: 30 · 2021: 22 · 2020: 18 · 2019: 6 · 2018: 1
- FWCI
- 7.21
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Inflammatory Bowel Diseases (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Aberdeen University Research Archive (Aberdeen University) (submittedVersion, cc-by-nc)
- Funders
- Rural and Environment Science and Analytical Services Division
- Scottish Government
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- Bacteroides thetaiotaomicron, Crohn's disease
- MeSH terms
- Bacteroides thetaiotaomicron, Animals, Colitis, Crohn Disease, Disease Models, Animal, Female, Humans, Inflammation, Mice, Inbred C57BL, Dextran Sulfate, Interleukin-10, Mice, Knockout, Caco-2 Cells, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.